Upper Airway of Women With Obstructive Sleep Apnea After Bariatric Surgery

December 19, 2022 updated by: Michel Burihan Cahali

Upper Airway of Women With Obstructive Sleep Apnea Changes After Bariatric Surgery and a Possible Influence of Menopause

Evaluation of upper airway with Magnetic Resonance and polysomnographic at the pre and post operative of 23 women having undergone bariatric surgery (with the Y-Roux technique) for treatment of obesity.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The the present study aims at describing the modifications occurring in the upper airway (UA) and the impact of such modifications on the severity of obstructive sleep apnea after bariatric surgery in women who have obstructive sleep apnea (OSA). The hypothesis is that the massive weight loss after bariatric surgery on OSA women could modify the UA more intensely than previously reported by other therapies for weight loss and that the menopause status may influence the likely reshaping of UA after bariatric surgery.

Study Type

Observational

Enrollment (Actual)

38

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Paraná
      • Cascavel, Paraná, Brazil, 85812-130
        • Fundação Hospitalar São Lucas

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

The patients were recruited in a center for the treatment of obesity after being referenced by the general practitioner to bariatric surgery. All patients apt for the bariatric surgery have attended weekly multi-professional accompaniment (medical, nursing, nutritional, physiotherapy and psychology) for a 16-week period, being subjected to weight loss through diet counselling, practice of physical activities and changes in life habits. The clinical and polysomnographic evaluations for this study have been carried out between 1 and 7 days before the bariatric surgeries. The magnetic resonance of the upper airways was performed on the eve of the bariatric surgery. At least 6 months after the surgeries, patients underwent a repeated polysomnography and Magnetic Resonance.

Description

Inclusion Criteria:

  • patients with a recommendation and considered apt for bariatric surgery by the multi-professional group
  • aged between 18 and 70
  • with a residual (after the 16-week period) BMI above 35 kg/m2
  • polysomnographic obstructive sleep apnea diagnosis: Apnea-Hypopnea Index (AHI) above 5 events per hour associated with a co-morbidity and/or complaints of snoring.

Exclusion Criteria:

  • patients with body weight above 180 kg - for the impossibility of having a magnetic resonance (MR)
  • carrying metal artifacts which contraindicate the performing of MR
  • patients with a history of pharyngeal or neoplasia in the head and neck region
  • patients affected by gross craniofacial deformities
  • pregnant women
  • previous UA surgery for OSA
  • patients undergoing any other treatment for OSA.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Upper airway changes after surgical weight loss
Time Frame: 6 months
Changes in weight (kilograms) measured before and six months after the bariatric surgery.
6 months
Obstructive sleep apnea parameters measured thought polysomnographic changes after weight loss
Time Frame: 6 months
Comparison of pre and post polysomnographic indexes: (apnea hypopnea index (AHI), arousals index, AHI at rapid eye movement (REM) sleep, AHI at supine position)
6 months
Changes in volumes and areas of upper airway
Time Frame: 6 months
Changes through MRI of measures upper airway and volume of tissues, as the percent of fat tissue within (in millimeters and %)
6 months
Correlation between the changes on upper airway with the changes on obstructive sleep apnea
Time Frame: 6 months
Pearson correlation between the changes occurred on upper airway measures and polysomnographic after the procedure
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluation if the menstrual status interfere on outcomes
Time Frame: 6 months
Participants are divided between menses and menopause groups; evaluation of the changes occurred on weight (kilograms), upper airway measures (millimeters and percentages) and polysomnographic (apnea hypopnea indexes) are different according menstrual status
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Michel Cahali, PhD, University of Sao Paulo General Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 15, 2017

Primary Completion (Actual)

March 25, 2021

Study Completion (Actual)

April 2, 2022

Study Registration Dates

First Submitted

November 12, 2022

First Submitted That Met QC Criteria

December 19, 2022

First Posted (Actual)

December 30, 2022

Study Record Updates

Last Update Posted (Actual)

December 30, 2022

Last Update Submitted That Met QC Criteria

December 19, 2022

Last Verified

December 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

as described in the informed consent form, the data collected in the research would not be shared with the patients, but they could, at the end of the study, request copies of the tests performed.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Bariatric surgery

Subscribe